How long does peptide therapy take to work?

How long peptide therapy takes to work depends on the specific peptide, how its dose is increased, and which result you are measuring. GLP-1 medicines start at a low dose that is raised in steps every four weeks, and reaching the higher doses can take four to five months. Weight loss usually builds during that time and keeps going after it. In the main trials, average weight loss continued for more than a year before leveling off at the 68- and 72-week endpoints. Other peptides follow their own clocks. The trials behind tesamorelin’s approval measured abdominal fat after 26 weeks. For peptides that have never been through human trials, there is no evidence-based timeline at all.

Nausea, vomiting, diarrhea and constipation are among the most common side effects of semaglutide and tirzepatide. Their FDA labels start at a low dose and step up every four weeks, which gives the digestive system time to adjust, and a clinician can slow that schedule if side effects are hard to tolerate.

That pacing shapes expectations. The first month is a starting dose meant for tolerance, so early weeks are about getting used to the medicine as much as results. Judging a GLP-1 after two or three weeks usually means judging it before it has had a fair trial. Our pages on semaglutide and tirzepatide explain how each is used at our clinic.

Useful markers change at different speeds. Body weight and waist size can be checked weekly at home. Lab markers, body composition and strength take longer to move, so they are rechecked at follow-up visits, and measuring them at the start is what makes later numbers meaningful.

We set those checkpoints at your first visit and compare each follow-up with your own baseline rather than with a promised timeline. If a medicine is not doing its job after a fair trial, that is a reason to revisit the plan with your clinician, not to push through on your own.

Checked October 30, 2026. Labels, guidelines and coverage rules change, so confirm anything that affects your care with your clinician or pharmacist.

• DailyMed - WEGOVY (semaglutide) injection and tablets prescribing information.
• DailyMed - ZEPBOUND (tirzepatide) prescribing information.
• Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384:989-1002.
• Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med. 2022;387:205-216.
• DailyMed - EGRIFTA SV (tesamorelin) prescribing information.

More from the Peptide Therapy FAQ: Does peptide therapy work? · What happens when you stop taking peptides? · Peptide half-life and administration · How peptide therapy works · Semaglutide in Las Vegas

Educational information from LiveNow Longevity, not medical advice. It gives no doses and does not replace an evaluation by a licensed clinician who knows your history.